These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21001626)

  • 1. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 6. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 7. Arsenical dermatitis treated with BAL.
    TINKLER AE
    Br Med J; 1947 Aug; 2(4518):227. PubMed ID: 20255547
    [No Abstract]   [Full Text] [Related]  

  • 8. Arsenical dermatitis successfully treated with BAL.
    REEVE JL
    Br Med J; 1947 Jul; 2(4516):132. PubMed ID: 20253734
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of arsenical dermatitis with dimercaptopropanol (BAL).
    CARLETON AB; PETERS RA; THOMPSON RH
    Q J Med; 1948 Jan; 17(65):49-79. PubMed ID: 18905506
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
    CARLETON AB; PETERS RA
    J Clin Invest; 1946 Jul; 25(4):497-527. PubMed ID: 21001625
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical uses of 2,3-dimercaptropropanol (BAL); the effect of BAL on the excretion of arsenic in normal subjects and after minimal exposure to arsenical smoke.
    WEXLER J; EAGLE H
    J Clin Invest; 1946 Jul; 25(4):467-73. PubMed ID: 21001621
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of acute gold and arsenic poisoning; use of BAL (2,3-dimercaptopropanol, British anti-lewisite).
    COHEN A; GOLDMAN J; DUBBS AW
    J Am Med Assoc; 1947 Mar; 133(11):749-52. PubMed ID: 20283984
    [No Abstract]   [Full Text] [Related]  

  • 16. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
    KOPPANYI T; SPERLING F
    Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Two cases of severe arsenical erythroderma, successfully treated with the new BAL compound].
    NOGUER-MORE
    Actas Dermosifiliogr; 1948 Jan; 39(4):498-507. PubMed ID: 18865721
    [No Abstract]   [Full Text] [Related]  

  • 18. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arsenical erythroma extinguished by B.A.L. and sodium thiosulfate].
    SMITH H
    Union Med Can; 1949 Dec; 78(12):1437. PubMed ID: 15394898
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.